

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 7.28208269 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.35977044 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.98305923 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.98305923 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.83601580 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82101052 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.82101052 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.45163269 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31352468 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.28929650 |
| 11 | urea metabolic process (GO:0019627) | 5.24113345 |
| 12 | urea cycle (GO:0000050) | 5.24113345 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 5.04840700 |
| 14 | phospholipid efflux (GO:0033700) | 5.03030128 |
| 15 | cysteine metabolic process (GO:0006534) | 5.01480349 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.98737077 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.98737077 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.98737077 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.98295118 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 4.96197607 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 4.93339643 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.90452442 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.78213281 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.77875474 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.73320084 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.71807418 |
| 27 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.68425254 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.67962993 |
| 29 | protein carboxylation (GO:0018214) | 4.67962993 |
| 30 | lipoprotein transport (GO:0042953) | 4.67345481 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.67016298 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65465596 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.60567858 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.60567858 |
| 35 | intestinal cholesterol absorption (GO:0030299) | 4.60032228 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 4.59638180 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.59421242 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.59421242 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59421242 |
| 40 | NADH metabolic process (GO:0006734) | 4.53046827 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.49691806 |
| 42 | regulation of protein activation cascade (GO:2000257) | 4.48291277 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48243041 |
| 44 | plasma lipoprotein particle assembly (GO:0034377) | 4.46530859 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44426217 |
| 46 | regulation of fibrinolysis (GO:0051917) | 4.44063546 |
| 47 | cholesterol efflux (GO:0033344) | 4.41274612 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37329395 |
| 49 | lysine metabolic process (GO:0006553) | 4.36281862 |
| 50 | lysine catabolic process (GO:0006554) | 4.36281862 |
| 51 | bile acid metabolic process (GO:0008206) | 4.29672178 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.27470943 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.27126802 |
| 54 | regulation of guanylate cyclase activity (GO:0031282) | 4.25055842 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.20835289 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.20835289 |
| 57 | regulation of cellular extravasation (GO:0002691) | 4.20475148 |
| 58 | regulation of complement activation (GO:0030449) | 4.19992639 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.16881665 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.16881665 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.11515604 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.11187590 |
| 63 | protein-lipid complex assembly (GO:0065005) | 4.07979291 |
| 64 | hormone catabolic process (GO:0042447) | 4.03226286 |
| 65 | drug catabolic process (GO:0042737) | 3.99705218 |
| 66 | serine family amino acid catabolic process (GO:0009071) | 3.95421535 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.94279153 |
| 68 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.93318895 |
| 69 | intestinal absorption (GO:0050892) | 3.89733433 |
| 70 | ethanol oxidation (GO:0006069) | 3.88364743 |
| 71 | cholesterol homeostasis (GO:0042632) | 3.81927065 |
| 72 | peptide catabolic process (GO:0043171) | 3.81893425 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.81157035 |
| 74 | cellular glucuronidation (GO:0052695) | 3.78785887 |
| 75 | lipoprotein metabolic process (GO:0042157) | 3.78182720 |
| 76 | sterol homeostasis (GO:0055092) | 3.76687621 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.75544707 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.72050225 |
| 79 | plasma lipoprotein particle organization (GO:0071827) | 3.71942883 |
| 80 | regulation of vitamin metabolic process (GO:0030656) | 3.71311788 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.68994485 |
| 82 | glycine metabolic process (GO:0006544) | 3.68830548 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 3.68201801 |
| 84 | flavonoid metabolic process (GO:0009812) | 3.68127167 |
| 85 | imidazole-containing compound metabolic process (GO:0052803) | 3.67613318 |
| 86 | diacylglycerol metabolic process (GO:0046339) | 3.65413626 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.58213351 |
| 88 | glycosphingolipid catabolic process (GO:0046479) | 3.57060264 |
| 89 | fructose metabolic process (GO:0006000) | 3.56344228 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.56133689 |
| 91 | glutamate metabolic process (GO:0006536) | 3.56115331 |
| 92 | protein-lipid complex subunit organization (GO:0071825) | 3.54370229 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.52573016 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.52453933 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49991196 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 3.49165217 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.48225098 |
| 98 | response to nitrosative stress (GO:0051409) | 3.47396088 |
| 99 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.46154082 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.45475109 |
| 101 | fibrinolysis (GO:0042730) | 3.45416884 |
| 102 | glycolipid catabolic process (GO:0019377) | 3.45264141 |
| 103 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.45012419 |
| 104 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.45012419 |
| 105 | endocrine process (GO:0050886) | 3.45012419 |
| 106 | drug metabolic process (GO:0017144) | 3.43701061 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.41308493 |
| 108 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.40628976 |
| 109 | cellular amino acid catabolic process (GO:0009063) | 3.38395394 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.36258354 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.35318685 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.35318685 |
| 113 | blood coagulation, intrinsic pathway (GO:0007597) | 3.35143509 |
| 114 | arginine metabolic process (GO:0006525) | 3.34074788 |
| 115 | coenzyme catabolic process (GO:0009109) | 3.31573681 |
| 116 | cellular biogenic amine catabolic process (GO:0042402) | 3.31510104 |
| 117 | amine catabolic process (GO:0009310) | 3.31510104 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.28531268 |
| 119 | cholesterol transport (GO:0030301) | 3.26906725 |
| 120 | sterol transport (GO:0015918) | 3.26906725 |
| 121 | ethanol metabolic process (GO:0006067) | 3.26750669 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.25470611 |
| 123 | drug transmembrane transport (GO:0006855) | 3.24558945 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 3.19840295 |
| 125 | virion attachment to host cell (GO:0019062) | 3.19840295 |
| 126 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.16363671 |
| 127 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.10545818 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 3.03949109 |
| 129 | antimicrobial humoral response (GO:0019730) | 3.02507144 |
| 130 | regulation of systemic arterial blood pressure (GO:0003073) | 3.01916592 |
| 131 | antibacterial humoral response (GO:0019731) | 3.00932043 |
| 132 | complement activation, classical pathway (GO:0006958) | 2.91975737 |
| 133 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87340923 |
| 134 | negative regulation of cell killing (GO:0031342) | 2.87340923 |
| 135 | exogenous drug catabolic process (GO:0042738) | 2.83738285 |
| 136 | adhesion of symbiont to host (GO:0044406) | 2.83267075 |
| 137 | renal system process involved in regulation of blood volume (GO:0001977) | 2.82680004 |
| 138 | positive regulation of pseudopodium assembly (GO:0031274) | 2.80379062 |
| 139 | ceramide catabolic process (GO:0046514) | 2.80002559 |
| 140 | detection of bacterium (GO:0016045) | 2.68776018 |
| 141 | alkaloid metabolic process (GO:0009820) | 2.66790623 |
| 142 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.66256418 |
| 143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66248537 |
| 144 | detection of other organism (GO:0098543) | 2.64963444 |
| 145 | peptide hormone processing (GO:0016486) | 2.63965309 |
| 146 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63085582 |
| 147 | leukotriene metabolic process (GO:0006691) | 2.59661350 |
| 148 | cellular response to reactive nitrogen species (GO:1902170) | 2.57451459 |
| 149 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.56969391 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55788535 |
| 151 | complement activation (GO:0006956) | 2.55677352 |
| 152 | thrombin receptor signaling pathway (GO:0070493) | 2.54033596 |
| 153 | NIK/NF-kappaB signaling (GO:0038061) | 2.53667000 |
| 154 | regulation of cGMP biosynthetic process (GO:0030826) | 2.50721140 |
| 155 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.49788182 |
| 156 | drug transport (GO:0015893) | 2.47961466 |
| 157 | citrulline biosynthetic process (GO:0019240) | 2.47477590 |
| 158 | sphingolipid catabolic process (GO:0030149) | 2.45031280 |
| 159 | regulation of pseudopodium assembly (GO:0031272) | 2.44347490 |
| 160 | transcytosis (GO:0045056) | 2.44001028 |
| 161 | digestive system process (GO:0022600) | 2.43711176 |
| 162 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.43356076 |
| 163 | cyclooxygenase pathway (GO:0019371) | 2.39889643 |
| 164 | oligosaccharide catabolic process (GO:0009313) | 2.39790089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.71932280 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.83121468 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.15104085 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.65169231 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.31645250 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72758273 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.32088964 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11018404 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.99505464 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.35675697 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.12848629 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69277596 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.56766898 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.37242261 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25969945 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.99283918 |
| 17 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95071569 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93581355 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82537073 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.80781864 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77486865 |
| 22 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.69855790 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68118948 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54516950 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49196793 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46048609 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45662306 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44769271 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40182659 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39764569 |
| 31 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35763668 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.35016282 |
| 33 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33253395 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33192357 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33033271 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32621115 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32044212 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30883088 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29213919 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28996760 |
| 41 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27592923 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25205283 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23462646 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22181909 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21742079 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21376056 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21245088 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20750149 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18526307 |
| 50 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15288065 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11399832 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11293041 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10921621 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10292573 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10241513 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09956204 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06988514 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06752433 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06532466 |
| 60 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06322294 |
| 61 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05469447 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04098250 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02700929 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02663285 |
| 65 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02370799 |
| 66 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95950140 |
| 67 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94910056 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94062250 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93527448 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92673284 |
| 71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91710608 |
| 72 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91353786 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91271366 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91125598 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90473741 |
| 76 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90323670 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89039035 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88245001 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86297333 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85228742 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83037491 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82272569 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82143250 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81932679 |
| 85 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81518455 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80451258 |
| 87 | * MAF_26560356_Chip-Seq_TH1_Human | 0.80183729 |
| 88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78377927 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77820310 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76909954 |
| 91 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75159774 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74665288 |
| 93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74416181 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73799592 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73251709 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 0.72664911 |
| 97 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72464943 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.72172549 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.71601278 |
| 100 | * MYB_26560356_Chip-Seq_TH1_Human | 0.70527077 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70246355 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.70104780 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69696516 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.69639692 |
| 105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68632015 |
| 106 | MYC_22102868_ChIP-Seq_BL_Human | 0.68282572 |
| 107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.68149347 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65860704 |
| 109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.65389999 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65017761 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64209610 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64046533 |
| 113 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63866529 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63195775 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63068937 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62899452 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 0.62625092 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62566260 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62209066 |
| 120 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62108412 |
| 121 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62006510 |
| 122 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.61437925 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61038354 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.60501351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.22657527 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.02685317 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.33219016 |
| 4 | MP0005365_abnormal_bile_salt | 4.99315169 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.39349266 |
| 6 | MP0009840_abnormal_foam_cell | 3.57695071 |
| 7 | MP0003252_abnormal_bile_duct | 3.56337991 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.43685430 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.31693497 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.08213025 |
| 11 | MP0005083_abnormal_biliary_tract | 2.67623395 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.57595616 |
| 13 | MP0005332_abnormal_amino_acid | 2.18608568 |
| 14 | MP0000609_abnormal_liver_physiology | 2.08579332 |
| 15 | MP0003866_abnormal_defecation | 2.03264327 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 1.99581454 |
| 17 | MP0003195_calcinosis | 1.91498738 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.87044151 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.82829895 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.70024149 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.67595167 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.65750479 |
| 23 | MP0005671_abnormal_response_to | 1.65715206 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.58549986 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.56058246 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.55598198 |
| 27 | MP0000490_abnormal_crypts_of | 1.46898077 |
| 28 | MP0003868_abnormal_feces_composition | 1.45694472 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.43549356 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42993766 |
| 31 | MP0009697_abnormal_copulation | 1.38505237 |
| 32 | MP0001764_abnormal_homeostasis | 1.37308304 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.36009991 |
| 34 | MP0003436_decreased_susceptibility_to | 1.32496445 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.32456541 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.31806070 |
| 37 | MP0001664_abnormal_digestion | 1.31278011 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.27368186 |
| 39 | MP0005409_darkened_coat_color | 1.27051197 |
| 40 | MP0002254_reproductive_system_inflammat | 1.26395297 |
| 41 | MP0009764_decreased_sensitivity_to | 1.23787960 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.23615982 |
| 43 | MP0003186_abnormal_redox_activity | 1.23335905 |
| 44 | MP0005670_abnormal_white_adipose | 1.23193565 |
| 45 | MP0001819_abnormal_immune_cell | 1.22820219 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.22109932 |
| 47 | MP0005451_abnormal_body_composition | 1.19340306 |
| 48 | MP0001663_abnormal_digestive_system | 1.18833168 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.18276413 |
| 50 | MP0002006_tumorigenesis | 1.17687430 |
| 51 | MP0008469_abnormal_protein_level | 1.17644731 |
| 52 | MP0000598_abnormal_liver_morphology | 1.17596552 |
| 53 | MP0003724_increased_susceptibility_to | 1.16785749 |
| 54 | MP0000477_abnormal_intestine_morphology | 1.14661583 |
| 55 | MP0000604_amyloidosis | 1.13884242 |
| 56 | MP0008004_abnormal_stomach_pH | 1.12793466 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.07067786 |
| 58 | MP0004947_skin_inflammation | 1.04464306 |
| 59 | MP0009763_increased_sensitivity_to | 1.02712523 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 0.99117486 |
| 61 | MP0005310_abnormal_salivary_gland | 0.97781426 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 0.96654798 |
| 63 | MP0001835_abnormal_antigen_presentation | 0.95845661 |
| 64 | MP0002998_abnormal_bone_remodeling | 0.95305813 |
| 65 | MP0009785_altered_susceptibility_to | 0.95227841 |
| 66 | MP0000858_altered_metastatic_potential | 0.93864075 |
| 67 | MP0000716_abnormal_immune_system | 0.92237014 |
| 68 | MP0002796_impaired_skin_barrier | 0.90300333 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.88364391 |
| 70 | MP0008260_abnormal_autophagy | 0.86566685 |
| 71 | MP0010155_abnormal_intestine_physiology | 0.86559019 |
| 72 | MP0009115_abnormal_fat_cell | 0.85993726 |
| 73 | MP0009642_abnormal_blood_homeostasis | 0.85911598 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.85145529 |
| 75 | MP0005381_digestive/alimentary_phenotyp | 0.85105762 |
| 76 | MP0010368_abnormal_lymphatic_system | 0.84973145 |
| 77 | MP0003011_delayed_dark_adaptation | 0.83927583 |
| 78 | MP0002405_respiratory_system_inflammati | 0.83680728 |
| 79 | MP0005025_abnormal_response_to | 0.83267994 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.83170179 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.82490411 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.82357517 |
| 83 | MP0000685_abnormal_immune_system | 0.81775173 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.81400122 |
| 85 | MP0005535_abnormal_body_temperature | 0.80230539 |
| 86 | MP0003448_altered_tumor_morphology | 0.79316101 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 0.78425621 |
| 88 | MP0002398_abnormal_bone_marrow | 0.76649211 |
| 89 | MP0005408_hypopigmentation | 0.76543722 |
| 90 | MP0004147_increased_porphyrin_level | 0.76181825 |
| 91 | MP0001853_heart_inflammation | 0.75654491 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.74093148 |
| 93 | MP0002419_abnormal_innate_immunity | 0.73740834 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.73456970 |
| 95 | MP0006054_spinal_hemorrhage | 0.73390501 |
| 96 | MP0002429_abnormal_blood_cell | 0.73022173 |
| 97 | MP0005165_increased_susceptibility_to | 0.72955075 |
| 98 | MP0001873_stomach_inflammation | 0.72726593 |
| 99 | MP0004858_abnormal_nervous_system | 0.72651289 |
| 100 | MP0006082_CNS_inflammation | 0.72417524 |
| 101 | MP0005647_abnormal_sex_gland | 0.72335829 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.70190784 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.69597251 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.66528765 |
| 105 | MP0001800_abnormal_humoral_immune | 0.65445344 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.65017847 |
| 107 | MP0005166_decreased_susceptibility_to | 0.63255005 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.62157461 |
| 109 | MP0002971_abnormal_brown_adipose | 0.62012002 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.61997850 |
| 111 | MP0005334_abnormal_fat_pad | 0.61668769 |
| 112 | MP0003303_peritoneal_inflammation | 0.61535659 |
| 113 | MP0005448_abnormal_energy_balance | 0.61233741 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.60602988 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.60285210 |
| 116 | MP0008873_increased_physiological_sensi | 0.60168765 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.59924228 |
| 118 | MP0001756_abnormal_urination | 0.57875476 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.57710027 |
| 120 | MP0003075_altered_response_to | 0.57150467 |
| 121 | MP0005387_immune_system_phenotype | 0.56431608 |
| 122 | MP0001790_abnormal_immune_system | 0.56431608 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.56003391 |
| 124 | MP0005023_abnormal_wound_healing | 0.55333706 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.54213946 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.54213946 |
| 127 | MP0000249_abnormal_blood_vessel | 0.53058329 |
| 128 | MP0001243_abnormal_dermal_layer | 0.52987788 |
| 129 | MP0002060_abnormal_skin_morphology | 0.52294209 |
| 130 | MP0002723_abnormal_immune_serum | 0.52219080 |
| 131 | MP0005266_abnormal_metabolism | 0.52121907 |
| 132 | MP0002132_abnormal_respiratory_system | 0.51528761 |
| 133 | MP0004130_abnormal_muscle_cell | 0.50501294 |
| 134 | MP0005501_abnormal_skin_physiology | 0.49956100 |
| 135 | MP0001881_abnormal_mammary_gland | 0.49927376 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.49755279 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.49251526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.36534622 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.19229756 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.15231366 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.85756481 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.81464142 |
| 6 | Xanthomatosis (HP:0000991) | 5.61012780 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.23424869 |
| 8 | Hypolipoproteinemia (HP:0010981) | 4.49308750 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41101009 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.37298492 |
| 11 | Chronic diarrhea (HP:0002028) | 4.35672714 |
| 12 | Complement deficiency (HP:0004431) | 4.32962958 |
| 13 | Joint hemorrhage (HP:0005261) | 4.11293249 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10362954 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06375710 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.99191141 |
| 17 | Hyperammonemia (HP:0001987) | 3.98521844 |
| 18 | Fat malabsorption (HP:0002630) | 3.96226869 |
| 19 | Epidermoid cyst (HP:0200040) | 3.94740090 |
| 20 | Acanthocytosis (HP:0001927) | 3.72598597 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68980127 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64728942 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.57655613 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.50278781 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.48318268 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.47476301 |
| 27 | Ketosis (HP:0001946) | 3.46071128 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37795729 |
| 29 | Abnormality of complement system (HP:0005339) | 3.33217201 |
| 30 | Hyperbilirubinemia (HP:0002904) | 3.31511564 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31490787 |
| 32 | Hyperglycinuria (HP:0003108) | 3.26969646 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.20898439 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15044196 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.15044196 |
| 36 | Hyperglycinemia (HP:0002154) | 3.10993884 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 3.09320123 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06974882 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.99926004 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96177232 |
| 41 | Myocardial infarction (HP:0001658) | 2.87691077 |
| 42 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.87243153 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.84047660 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.79763310 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.79406556 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.78520455 |
| 47 | Poikilocytosis (HP:0004447) | 2.76241778 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.75447890 |
| 49 | Hyperactive renin-angiotensin system (HP:0000841) | 2.67524877 |
| 50 | Steatorrhea (HP:0002570) | 2.65367131 |
| 51 | Metabolic acidosis (HP:0001942) | 2.64341641 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63493383 |
| 53 | Malnutrition (HP:0004395) | 2.62805791 |
| 54 | Abnormality of vitamin B metabolism (HP:0004340) | 2.61698898 |
| 55 | Ketoacidosis (HP:0001993) | 2.56249644 |
| 56 | Spastic diplegia (HP:0001264) | 2.55739500 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.54915456 |
| 58 | Myositis (HP:0100614) | 2.54199593 |
| 59 | Gingivitis (HP:0000230) | 2.53304926 |
| 60 | Orchitis (HP:0100796) | 2.53183022 |
| 61 | Esophageal varix (HP:0002040) | 2.53151813 |
| 62 | Flat acetabular roof (HP:0003180) | 2.46784297 |
| 63 | Vasculitis (HP:0002633) | 2.46170213 |
| 64 | Abnormal gallbladder physiology (HP:0012438) | 2.45703940 |
| 65 | Cholecystitis (HP:0001082) | 2.45703940 |
| 66 | Gingival bleeding (HP:0000225) | 2.44119873 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.42730096 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.41973645 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.41973645 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41045030 |
| 71 | Abdominal distention (HP:0003270) | 2.38250295 |
| 72 | Vascular calcification (HP:0004934) | 2.36543326 |
| 73 | Skin nodule (HP:0200036) | 2.36453813 |
| 74 | Thin bony cortex (HP:0002753) | 2.36404629 |
| 75 | Spontaneous abortion (HP:0005268) | 2.35726794 |
| 76 | Metabolic alkalosis (HP:0200114) | 2.35119977 |
| 77 | Amyloidosis (HP:0011034) | 2.35085263 |
| 78 | Alkalosis (HP:0001948) | 2.34795083 |
| 79 | Abnormality of vitamin metabolism (HP:0100508) | 2.34534814 |
| 80 | Polycythemia (HP:0001901) | 2.34118236 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.33704078 |
| 82 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.33442540 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.32776834 |
| 84 | Colitis (HP:0002583) | 2.32562976 |
| 85 | Cholelithiasis (HP:0001081) | 2.32247183 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.31754368 |
| 87 | Glomerulonephritis (HP:0000099) | 2.29890432 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.28128958 |
| 89 | Confusion (HP:0001289) | 2.27798729 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.26594236 |
| 91 | Gastrointestinal infarctions (HP:0005244) | 2.26381908 |
| 92 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.25625181 |
| 93 | Villous atrophy (HP:0011473) | 2.25625181 |
| 94 | Hypophosphatemia (HP:0002148) | 2.25418345 |
| 95 | Decreased circulating renin level (HP:0003351) | 2.25083375 |
| 96 | Reticulocytosis (HP:0001923) | 2.24044592 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 2.23803405 |
| 98 | Menorrhagia (HP:0000132) | 2.23297853 |
| 99 | Petechiae (HP:0000967) | 2.20300447 |
| 100 | Inflammation of the large intestine (HP:0002037) | 2.19721675 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19673584 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.19673584 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 2.19591565 |
| 104 | Pustule (HP:0200039) | 2.18993765 |
| 105 | Thrombophlebitis (HP:0004418) | 2.18741145 |
| 106 | Wide cranial sutures (HP:0010537) | 2.17193304 |
| 107 | Abnormal platelet volume (HP:0011876) | 2.16559954 |
| 108 | Meningitis (HP:0001287) | 2.15909306 |
| 109 | Encephalitis (HP:0002383) | 2.14816960 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 2.13924525 |
| 111 | Hypochromic microcytic anemia (HP:0004840) | 2.12846520 |
| 112 | Gout (HP:0001997) | 2.11520398 |
| 113 | Pancreatitis (HP:0001733) | 2.10450575 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.10306170 |
| 115 | Mitral stenosis (HP:0001718) | 2.09286331 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 2.08513333 |
| 117 | Increased serum ferritin (HP:0003281) | 2.07484395 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.07235460 |
| 119 | Late onset (HP:0003584) | 2.06826078 |
| 120 | Ileus (HP:0002595) | 2.06571375 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 2.05300535 |
| 122 | Pulmonary infiltrates (HP:0002113) | 2.05172492 |
| 123 | Optic neuritis (HP:0100653) | 2.02848644 |
| 124 | Retrobulbar optic neuritis (HP:0100654) | 2.02848644 |
| 125 | Gastrointestinal stroma tumor (HP:0100723) | 2.01477839 |
| 126 | Joint swelling (HP:0001386) | 2.01307173 |
| 127 | Generalized aminoaciduria (HP:0002909) | 2.00784308 |
| 128 | Purpura (HP:0000979) | 2.00258454 |
| 129 | Lethargy (HP:0001254) | 2.00006456 |
| 130 | Obstructive lung disease (HP:0006536) | 1.98728973 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98728973 |
| 132 | Abnormal platelet function (HP:0011869) | 1.98392953 |
| 133 | Impaired platelet aggregation (HP:0003540) | 1.98392953 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.98089093 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 1.97370738 |
| 136 | Mediastinal lymphadenopathy (HP:0100721) | 1.97233583 |
| 137 | Skin rash (HP:0000988) | 1.96453457 |
| 138 | Hemorrhage of the eye (HP:0011885) | 1.94643326 |
| 139 | Neonatal onset (HP:0003623) | 1.94089047 |
| 140 | Nephrolithiasis (HP:0000787) | 1.93876835 |
| 141 | Epistaxis (HP:0000421) | 1.91721121 |
| 142 | Nausea (HP:0002018) | 1.91023779 |
| 143 | Nephritis (HP:0000123) | 1.90152053 |
| 144 | Facial shape deformation (HP:0011334) | 1.89212435 |
| 145 | Potter facies (HP:0002009) | 1.89212435 |
| 146 | Irritability (HP:0000737) | 1.88527730 |
| 147 | Recurrent fungal infections (HP:0002841) | 1.88378988 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.88329722 |
| 149 | Hypotension (HP:0002615) | 1.86681422 |
| 150 | Abnormal glucose tolerance (HP:0001952) | 1.85793722 |
| 151 | Glycosuria (HP:0003076) | 1.85661764 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.85661764 |
| 153 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84313083 |
| 154 | Abnormality of renin-angiotensin system (HP:0000847) | 1.83313352 |
| 155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83309715 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83185026 |
| 157 | Hypertriglyceridemia (HP:0002155) | 1.82985824 |
| 158 | Recurrent viral infections (HP:0004429) | 1.82637970 |
| 159 | Urticaria (HP:0001025) | 1.81586849 |
| 160 | Dysostosis multiplex (HP:0000943) | 1.81530044 |
| 161 | Brushfield spots (HP:0001088) | 1.81372736 |
| 162 | Hemoptysis (HP:0002105) | 1.80418233 |
| 163 | Increased purine levels (HP:0004368) | 1.79825855 |
| 164 | Hyperuricemia (HP:0002149) | 1.79825855 |
| 165 | Agammaglobulinemia (HP:0004432) | 1.79798417 |
| 166 | Enlarged epiphyses (HP:0010580) | 1.79483541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.18219608 |
| 2 | BCKDK | 3.72558618 |
| 3 | FGFR4 | 3.20207705 |
| 4 | PKN2 | 2.83711560 |
| 5 | MST1R | 2.80764348 |
| 6 | SIK1 | 2.69238952 |
| 7 | TAOK3 | 2.60112132 |
| 8 | TRIB3 | 2.59442220 |
| 9 | RIPK4 | 2.55205748 |
| 10 | FRK | 2.47747127 |
| 11 | TYK2 | 2.41053925 |
| 12 | MAP4K1 | 2.36148461 |
| 13 | TBK1 | 2.14131314 |
| 14 | PRPF4B | 2.10655040 |
| 15 | FLT3 | 2.07313542 |
| 16 | PTK6 | 1.96990618 |
| 17 | GRK6 | 1.96854541 |
| 18 | MAP3K10 | 1.95638549 |
| 19 | KDR | 1.75331806 |
| 20 | STK10 | 1.61139973 |
| 21 | MAP3K14 | 1.59950265 |
| 22 | MAP2K3 | 1.57461695 |
| 23 | LRRK2 | 1.54373179 |
| 24 | ZAP70 | 1.49079362 |
| 25 | MAPK11 | 1.44850482 |
| 26 | NEK9 | 1.39686290 |
| 27 | RIPK1 | 1.38337999 |
| 28 | JAK3 | 1.37529838 |
| 29 | JAK1 | 1.36913778 |
| 30 | MAP3K3 | 1.32211285 |
| 31 | BLK | 1.30108447 |
| 32 | JAK2 | 1.29971498 |
| 33 | EEF2K | 1.29384307 |
| 34 | TGFBR2 | 1.27931828 |
| 35 | TAOK1 | 1.24481461 |
| 36 | STK39 | 1.23400678 |
| 37 | MAP3K11 | 1.23237510 |
| 38 | SCYL2 | 1.22760774 |
| 39 | IKBKE | 1.21962463 |
| 40 | BMPR2 | 1.20935702 |
| 41 | PIK3CA | 1.18092219 |
| 42 | MST4 | 1.17031828 |
| 43 | PIK3CG | 1.16789670 |
| 44 | ERBB4 | 1.14071590 |
| 45 | KIT | 1.12967755 |
| 46 | CDC42BPA | 1.09281766 |
| 47 | CDK6 | 1.09062152 |
| 48 | PDK2 | 1.06257200 |
| 49 | MAP3K12 | 1.05478691 |
| 50 | DDR2 | 1.05131207 |
| 51 | NME2 | 1.03911239 |
| 52 | INSRR | 1.01728369 |
| 53 | CSK | 1.00927124 |
| 54 | MAP3K7 | 1.00350519 |
| 55 | EPHB1 | 1.00034488 |
| 56 | CSF1R | 0.98628322 |
| 57 | PRKG2 | 0.95334413 |
| 58 | PDPK1 | 0.92233561 |
| 59 | IRAK3 | 0.91822382 |
| 60 | BTK | 0.91112071 |
| 61 | FGR | 0.90609200 |
| 62 | NLK | 0.88549595 |
| 63 | ABL2 | 0.87256766 |
| 64 | FGFR3 | 0.86313662 |
| 65 | RPS6KA4 | 0.80511435 |
| 66 | ITK | 0.79854606 |
| 67 | PDK1 | 0.79790779 |
| 68 | TAOK2 | 0.79502635 |
| 69 | PRKAA2 | 0.78008641 |
| 70 | OXSR1 | 0.76903457 |
| 71 | STK24 | 0.76727843 |
| 72 | MAPK4 | 0.73612202 |
| 73 | LATS1 | 0.72838459 |
| 74 | PIM2 | 0.72669310 |
| 75 | SMG1 | 0.72379118 |
| 76 | TESK1 | 0.72350066 |
| 77 | CDK4 | 0.70560127 |
| 78 | MAP2K2 | 0.69975959 |
| 79 | MAP2K4 | 0.68947363 |
| 80 | MAP3K8 | 0.68592979 |
| 81 | MAP2K6 | 0.65988961 |
| 82 | EPHA2 | 0.65265904 |
| 83 | IRAK1 | 0.64731173 |
| 84 | FES | 0.64704329 |
| 85 | MAP3K2 | 0.64388530 |
| 86 | TEC | 0.63766644 |
| 87 | SYK | 0.63436775 |
| 88 | LMTK2 | 0.63141423 |
| 89 | CAMK1D | 0.60133355 |
| 90 | IKBKB | 0.59353383 |
| 91 | HCK | 0.57936839 |
| 92 | MAP3K13 | 0.56141379 |
| 93 | MET | 0.55346368 |
| 94 | DAPK2 | 0.55076029 |
| 95 | PRKCQ | 0.54972280 |
| 96 | TIE1 | 0.54191312 |
| 97 | TGFBR1 | 0.53719604 |
| 98 | NUAK1 | 0.53446441 |
| 99 | PAK4 | 0.52057715 |
| 100 | PDGFRA | 0.51010675 |
| 101 | PTK2 | 0.50083092 |
| 102 | DYRK1B | 0.49801624 |
| 103 | MAP3K1 | 0.49530619 |
| 104 | MAP3K5 | 0.49275864 |
| 105 | ERBB2 | 0.49208753 |
| 106 | FYN | 0.47807022 |
| 107 | MAPKAPK3 | 0.46988815 |
| 108 | LYN | 0.46831895 |
| 109 | RET | 0.46578960 |
| 110 | CHUK | 0.46345153 |
| 111 | ACVR1B | 0.46287547 |
| 112 | ICK | 0.45870398 |
| 113 | MATK | 0.45807487 |
| 114 | PIM1 | 0.45280479 |
| 115 | EIF2AK1 | 0.44291405 |
| 116 | IRAK4 | 0.43887233 |
| 117 | EGFR | 0.43646273 |
| 118 | MELK | 0.42477604 |
| 119 | BMX | 0.42364728 |
| 120 | STK3 | 0.41757290 |
| 121 | LCK | 0.41102327 |
| 122 | MAP2K1 | 0.40405992 |
| 123 | GSK3A | 0.40209392 |
| 124 | TESK2 | 0.39746265 |
| 125 | EPHA3 | 0.39357409 |
| 126 | YES1 | 0.38689078 |
| 127 | TXK | 0.38458971 |
| 128 | PRKACG | 0.38441651 |
| 129 | FER | 0.37062069 |
| 130 | MAPKAPK2 | 0.36155191 |
| 131 | EPHB2 | 0.35157432 |
| 132 | IGF1R | 0.34614211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06584662 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49159843 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33510314 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95543121 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86896694 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59909167 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51389604 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42913945 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39577601 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.38018299 |
| 11 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.36188878 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34724722 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.11986222 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.09781948 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09385170 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07911532 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06590999 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.06353037 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98959728 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98199048 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88217613 |
| 22 | * Peroxisome_Homo sapiens_hsa04146 | 1.87851839 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.87753198 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87493264 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86073356 |
| 26 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84525651 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84102523 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67818256 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66823578 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64691913 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62605172 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61539944 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61156789 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.60960972 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60790037 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58433585 |
| 37 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55549788 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52591628 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50125133 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47042148 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.46388576 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44387628 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.41847595 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40022965 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35312955 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34748578 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34238453 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29550485 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27348546 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22086942 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21692925 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21200546 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18775528 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17654161 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17466733 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17264000 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16289343 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15900891 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11002757 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07783222 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03323074 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01765526 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98763804 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96718422 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92012251 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91248320 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90231032 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89956659 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87208796 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83942241 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83136394 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.81542877 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77669281 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.75617081 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74756622 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73548837 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71779605 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.70559173 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68456847 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68038802 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64336210 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64163433 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59501923 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56103899 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55857178 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54667162 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51392571 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50134543 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49745970 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47376890 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45612190 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45150344 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.42095682 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.39861672 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38983347 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38884321 |
| 97 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38471502 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.36317983 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36314162 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34442252 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33324419 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.32442534 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31889197 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.31368723 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.29497233 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28049672 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27794764 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.25242790 |
| 109 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20651061 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20566974 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.18422173 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16370527 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.15815353 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12811893 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10511258 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08268691 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.08184243 |
| 118 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07722664 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.07612141 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.06398201 |
| 121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.00810156 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | -0.0745178 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0736858 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0633447 |
| 125 | * Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0624673 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0568021 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0501444 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0472723 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0382367 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0344472 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0283312 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0236305 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0089057 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0027843 |
| 135 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0010830 |

